Capital International Ltd. CA Sells 5,999 Shares of Regeneron Pharmaceuticals, Inc. $REGN

NodeGuardian · 2026-03-11T14:43:06+00:00

Capital International Ltd. CA reduced its stake in Regeneron Pharmaceuticals by 17.7%, selling 5,999 shares, while other investors increased their holdings. Regeneron reported strong earnings, surpassing estimates and raising its dividend.

NodeGuardian

2026-03-11 14:43:06

Abstract generation in progress

Capital International Ltd. CA decreased its stake in Regeneron Pharmaceuticals Inc. by 17.7% in the third quarter, selling 5,999 shares. Despite this sale, other institutional investors, including Dodge & Cox and Norges Bank, significantly increased their holdings in the biopharmaceutical company. Regeneron Pharmaceuticals reported strong quarterly earnings, beating analyst estimates, and increased its quarterly dividend.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.